| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 02/19/2014 | EP2697228A1 Cgrp receptor antagonists |
| 02/19/2014 | EP2697227A1 Fused imidazole derivatives useful as ido inhibitors |
| 02/19/2014 | EP2697226A1 Compounds for electronic devices |
| 02/19/2014 | EP2697225A1 Materials for electronic devices |
| 02/19/2014 | EP2697205A1 Asymmetrically substituted anthrapyridazone derivatives as cytostatics |
| 02/19/2014 | CN103596958A Tetrahydropyrazolo [1,5 -a] pyrimidine as anti -tuberculosis compounds |
| 02/19/2014 | CN103596957A Imidazopyridazines as AKT kinase inhibitors |
| 02/19/2014 | CN103596956A Pyrazolo[3,4-d]pyrimidine compounds and their use as PDE2 inhibitors and/or cyp3A4 inhibitors |
| 02/19/2014 | CN103596929A Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators |
| 02/19/2014 | CN103596926A Fused tricyclic compounds as RAF kinase inhibitors |
| 02/19/2014 | CN103588792A Pyrazolopyrimidine or pyrimidinopyrimidine compounds, preparation method therefor, pharmaceutical compositions thereof and applications thereof |
| 02/19/2014 | CN103588771A Pyrimidine antitumor compound with Hedgehog antagonist activity |
| 02/19/2014 | CN103588712A Pyrimidine compound and preparation method and application thereof |
| 02/18/2014 | USRE44768 Rapamycin hydroxyesters |
| 02/18/2014 | US8653268 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors |
| 02/18/2014 | US8653260 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists |
| 02/18/2014 | US8653127 Bicyclic pyrazolo-heterocycles |
| 02/18/2014 | US8653097 Tetra-aza-heterocycles as phosphatidylinositol-3-kinases (P13-kinases) inhibitor |
| 02/18/2014 | US8653088 Compositions useful as inhibitors of protein kinases |
| 02/18/2014 | US8653087 Pyrido [5, 4-D] pyrimidines as cell proliferation inhibitors |
| 02/18/2014 | US8653077 Inhibitors of human phosphatidylinositol 3-kinase delta |
| 02/18/2014 | US8653076 Oxo-substituted imidazo[1,2B]pyridazines, their preparation and use as pharmaceuticals |
| 02/18/2014 | US8653064 Crystalline forms of sodium 4-{[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-D][2]benzazepin-2-yl]amino}-2-methoxybenzoate |
| 02/18/2014 | CA2701594C Heterocycle phenyl amide t-type calcium channel antagonists |
| 02/18/2014 | CA2624492C Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 02/18/2014 | CA2564076C Chemical linkers and conjugates thereof |
| 02/13/2014 | WO2014026125A1 Pyrazine derivatives as fgfr inhibitors |
| 02/13/2014 | WO2014025486A1 Novel pyrrolopyrimidine compounds as inhibitors of protein kinases |
| 02/13/2014 | WO2014025209A1 Novel compound and organic electroluminescence device comprising same |
| 02/13/2014 | WO2014024164A1 Process for the preparation of pemetrexed and lysin salt thereof |
| 02/13/2014 | WO2014024125A1 Pyrazolo[4,3-d]pyrimidin-7(6h)-one derivatives as pde9 inhibitors |
| 02/13/2014 | WO2014024119A1 Heterocyclic amides as itk inhibitors |
| 02/13/2014 | WO2014023930A1 Process for the preparation of sitagliptin and intermediate compounds |
| 02/13/2014 | WO2014023723A1 Subtituted azines as pesticides |
| 02/13/2014 | WO2014023674A1 Piperazino[1,2-a]indol-1-ones and [1,4]diazepino[1,2-a]indol-1-one |
| 02/13/2014 | WO2014023639A1 Radiation-curable formulations with high adhesion |
| 02/13/2014 | WO2014023191A1 N-substituted pyrazolo [3, 4-d] pyrimidine ketone compound and preparation method and application thereof |
| 02/13/2014 | US20140046056 Fused ring compound and use thereof |
| 02/13/2014 | US20140046055 Compounds and methods for inhibiting mitotic progression |
| 02/13/2014 | US20140045856 4-Methyl-2,3,5,9,9b-pentaaza-cyclopenta[a]naphthalenes |
| 02/13/2014 | US20140045854 Methods and Compositions for the Treatment of Cancer and Related Hyperproliferative Disorders |
| 02/13/2014 | US20140045849 Pyrimidine derivatives for the treatment of viral infections |
| 02/13/2014 | US20140045836 [1,2,4]triazolo[1,5-c]pyrimidine derivatives as hsp90 modulators |
| 02/13/2014 | US20140045833 Protein Kinase Inhibitors |
| 02/13/2014 | US20140045827 NOVEL ANTIFUNGAL 5,6-DIHYDRO-4H-PYRROLO[1,2-a][1,4]BENZO-DIAZEPINES AND 6H-PYRROLO[1,2-a][1,4]BENZODIAZEPINES SUBSTITUTED WITH HETEROCYCLIC DERIVATIVES |
| 02/13/2014 | US20140045826 Methods and compositions for treating neurodegenerative diseases |
| 02/13/2014 | US20140045821 Protein kinase d inhibitors |
| 02/13/2014 | US20140045819 Aldosterone synthase inhibitors |
| 02/13/2014 | US20140045816 Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors |
| 02/13/2014 | US20140045814 Pyrazine derivatives as fgfr inhibitors |
| 02/13/2014 | US20140045802 4-(4-cyano-2-thioaryl)dihydropyrimidinones and their use |
| 02/13/2014 | US20140045779 Compounds containing an alicyclie structure and anti-tumor application |
| 02/12/2014 | EP2695883A2 Tricyclic derivatives of n,n'-substituted 3,7-diazabicyclo [3.3.1]nonanes and drugs based thereon |
| 02/12/2014 | EP2694517A1 Protein kinase inhibitors |
| 02/12/2014 | EP2694516A1 Process for obtaining a charge of hexanitrohexaazaisowurtzitane crystals having a rounded morphology; charge and corresponding energetic material |
| 02/12/2014 | EP2694515A1 Protein kinase inhibitors |
| 02/12/2014 | EP2694514A2 New intermediates and processes for preparing ticagrelor |
| 02/12/2014 | EP2694513A1 Pyrazolo pyrimidine derivatives |
| 02/12/2014 | EP2694512A1 Crystalline and non- crystalline forms of tofacitinib, and a pharmaceutical composition comprising tofacitinib and a penetration enhancer |
| 02/12/2014 | EP2694511A1 Dihydropyrrolo pyrimidine derivatives as mtor inhibitors |
| 02/12/2014 | EP2694510A1 Imidazopyridazines as akt kinase inhibitors |
| 02/12/2014 | EP2694509A1 Pyrrolo [2, 3 -d]pyrimidine derivatives as inhibitors of tropomyosin- related kinases |
| 02/12/2014 | EP2694508A1 Substituted 2,3-dihydroimidazo[1,2-c]quinazoline salts |
| 02/12/2014 | EP2694507A1 N-substituted hetero-bicyclic compounds and derivatives for combating animal pests |
| 02/12/2014 | EP2693882A1 Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment |
| 02/12/2014 | EP2693876A1 Substituted methylformyl reagents and method of using same to modify physicochemical and/or pharmacokinetic properties of compounds |
| 02/12/2014 | CN103582644A Novel phthalazinone-pyrrolopyrimidinecarboxamide derivatives |
| 02/12/2014 | CN103582643A 蛋白激酶抑制剂 Protein kinase inhibitors |
| 02/12/2014 | CN103582630A Neprilysin inhibitors |
| 02/12/2014 | CN103582482A Pharmaceutically active disubstituted triazine derivatives |
| 02/12/2014 | CN103571502A Liquid crystal aligning agent and compound |
| 02/12/2014 | CN103570742A Condensation compound and organic light emitting device including same |
| 02/12/2014 | CN103570735A Novel heterocyclic compounds and organic light emitting device comprising the same |
| 02/12/2014 | CN103570734A Synthesis method of cobalt phthalocyanine diamine compound |
| 02/12/2014 | CN103570733A Porphyrins and preparation method and application thereof |
| 02/12/2014 | CN103570732A Porphin compound, as well as preparation method and application thereof |
| 02/12/2014 | CN103570731A Pyrimidotricyclic compounds or pyrimidotetracyclic compounds, pharmaceutical composition and applications thereof |
| 02/12/2014 | CN103570730A Condensed ring pyridazinone compound with bridge ring structure as well as preparation method and application thereof |
| 02/12/2014 | CN103570729A Bicyclic neonicotine compounds constructed by cycloalkenone, and preparation method and application thereof |
| 02/12/2014 | CN103570728A Substituted pyrazolo[1,5-a]pyrimidine derivatives as well as preparation method and application thereof |
| 02/12/2014 | CN103570727A N-benzyl tryptanthrin derivative, as well as preparation method and use thereof |
| 02/12/2014 | CN103570726A N-alkyl tryptanthrin derivative, as well as preparation method and application thereof |
| 02/12/2014 | CN103570725A Piperazidinoltriazole compound as well as preparation method and application thereof |
| 02/12/2014 | CN103570724A Synthesis method of ponatinib |
| 02/12/2014 | CN103570723A Pyrazolopyrimidine derivative, its preparation method, and its use in preparation of medicines |
| 02/12/2014 | CN103570722A Fused ring pyridazinone compounds, preparation method and uses thereof |
| 02/12/2014 | CN103570721A Triazolopyrazine(one) and isoxazolopiperidone compounds |
| 02/12/2014 | CN103570693A Bridged compound serving as hepatitis C inhibitor and application of bridged compound in medicines |
| 02/12/2014 | CN103570630A Heterocyclic nitrogen derivative and application thereof in medicines |
| 02/12/2014 | CN103570625A N-(3-aryl-heteroaryl)-4-aryl-aryl carboxamide and analog as hedgehog pathway inhibitors and application thereof |
| 02/12/2014 | CN101889016B Pyrrolopyrrole derivatives, their manufacture and use |
| 02/11/2014 | US8648085 1, 5-dihydro-pyrazolo (3, 4-D) pyrimidin-4-one derivatives and their use as PDE9A mudulators for the treatment of CNS disorders |
| 02/11/2014 | US8648076 Cysteine protease inhibitors and their therapeutic applications |
| 02/11/2014 | CA2778291C Akt inhibitors |
| 02/11/2014 | CA2743257C Novel tricyclic derivative or pharmaceutically acceptable salts thereof, preparation method thereof, and pharmaceutical composition containing the same |
| 02/11/2014 | CA2572121C Pyrimido-benzimidazole derivatives and the use thereof in the form of agonists or antagonists of melanocortin receptors |
| 02/11/2014 | CA2288330C Benzoyl amino acid derivatives useful as inhibitors of protein isoprenyl tranferases |
| 02/06/2014 | WO2014022767A1 Dihydropyridone p1 as factor xia inhibitors |
| 02/06/2014 | WO2014022766A1 Dihydropyridone p1 as factor xia inhibitors |
| 02/06/2014 | WO2014022741A1 Paa nanoparticles for pet imaging and pdt treatment |